Cresset Asset Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,544
Closed -$362K 1471
2025
Q1
$362K Sell
18,544
-8,926
-32% -$234K ﹤0.01% 1227
2024
Q4
$681K Sell
27,470
-10,650
-28% -$272K ﹤0.01% 955
2024
Q3
$934K Sell
38,120
-8,528
-18% -$220K ﹤0.01% 1196
2024
Q2
$1.09M Buy
46,648
+36,036
+340% +$885K ﹤0.01% 1013
2024
Q1
$351K Buy
10,612
+289
+3% +$9K ﹤0.01% 1501
2023
Q4
$281K Buy
+10,323
New +$256K ﹤0.01% 1522
2022
Q1
Sell
-4,974
Closed -$396K 1000
2021
Q4
$396K Buy
4,974
+1,151
+30% +$98.6K ﹤0.01% 775
2021
Q3
$333K Hold
3,823
﹤0.01% 800
2021
Q2
$492K Sell
3,823
-5,981
-61% -$477K 0.01% 556
2021
Q1
$785K Buy
9,804
+7,170
+272% +$682K 0.01% 356
2020
Q4
$215K Buy
+2,634
New +$130K ﹤0.01% 687

Other funds holding BEAM